1. Home
  2. FSP vs ATNM Comparison

FSP vs ATNM Comparison

Compare FSP & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

HOLD

Current Price

$0.37

Market Cap

33.3M

Sector

Real Estate

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.06

Market Cap

37.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSP
ATNM
Founded
1981
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
37.1M
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
FSP
ATNM
Price
$0.37
$1.06
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $3.60
AVG Volume (30 Days)
★ 783.1K
110.5K
Earning Date
10-27-2026
11-13-2026
Dividend Yield
★ 5.88%
N/A
EPS Growth
★ 15.69
14.17
EPS
N/A
★ 0.71
Revenue
★ $107,162,000.00
$90,000.00
Revenue This Year
$16.75
$19,344.45
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$1.54
Revenue Growth
N/A
★ 11.11
52 Week Low
$0.30
$0.74
52 Week High
$1.49
$1.74

Technical Indicators

Market Signals
Indicator
FSP
ATNM
Relative Strength Index (RSI) 53.44 40.39
Support Level $0.32 $0.98
Resistance Level $0.38 $1.13
Average True Range (ATR) 0.02 0.06
MACD 0.01 -0.02
Stochastic Oscillator 76.74 8.70

Price Performance

Historical Comparison
FSP
ATNM

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: